Litcius/Paper detail

APOBEC mutagenesis, kataegis, chromothripsis in EGFR-mutant osimertinib-resistant lung adenocarcinomas

Pier Selenica, Antonio Marra, Noura J. Choudhury, Andrea Gazzo, Christina J. Falcon, Juber Patel, Xin Pei, Yingjie Zhu, Charlotte K.Y. Ng, Michael Curry, Glenn Heller, Y.-K. Zhang, M.F. Berger, Marc Ladanyi, Charles M. Rudin, Sarat Chandarlapaty, Christine M. Lovly, Jorge S. Reis‐Filho, Helena A. Yu

2022Annals of Oncology53 citationsDOIOpen Access PDF

Topics & Concepts

APOBECOsimertinibCancer researchLung cancerEpidermal growth factor receptorBiologyCrizotinibAdenocarcinomaMutationMutantCancerMedicineGeneticsGenePathologyErlotinibGenomeMalignant pleural effusionLung Cancer Treatments and MutationsCancer Genomics and DiagnosticsMelanoma and MAPK Pathways
APOBEC mutagenesis, kataegis, chromothripsis in EGFR-mutant osimertinib-resistant lung adenocarcinomas | Litcius